Palatin Technologies, Inc. (PTN)
22.40
+1.50
(+7.18%)
USD |
NYAM |
Mar 02, 16:00
22.45
+0.05
(+0.22%)
After-Hours: 16:52
Palatin Technologies Research and Development Expense (Annual) : 14.90M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 78.03M |
| BioMarin Pharmaceutical, Inc. | 700.97M |
| Imunon, Inc. | 11.64M |